This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Timing can make a difference in redeeming credit card rewards. Discover the best moments to redeem for maximum value.
23,399 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
A high-profile fund sold a sizable GRAIL stake right before a dramatic 50% one-day drop. This article unpacks the mov...
Gold and silver slid this week as geopolitical risk and higher oil costs pressured bullion, while Bitcoin bucked the ...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...
The growing problem ‘tech addiction’ is fueling a new detox economy as clinics, apps, and coaching services help peop...
A bold market prediction centers on Nvidia stock rising 150% by 2028—but only if a single, enduring driver keeps AI s...
A federal judge blocked the Trump administration from labeling Anthropic a supply chain risk, calling the move a poss...
A high-profile ethics allegation shines a light on how disaster-relief money can intersect with politics and personal...
Amazon launches a $200 billion AI-focused capex plan for 2026, with Trainium and Anthropic in the mix. Here’s what in...
Gold has surged roughly 50% in the past year, but most portfolios remain lightly exposed. State Street’s 2026 outlook...
Alphabet signals a strategic shift toward edge AI, with Chrome devices potentially shouldering more inference work. T...
This in-depth guide helps investors decode McDonald's 2026 earnings by examining the Q1 transcript, key drivers, and ...